Review summary
Teaching objective: Recognizing and managing a restrictive eating disorder in a 56-year-old woman who presents with weight loss, fatigue, ankle swelling and dizziness, with compulsive exercise and frequent self-weighing since early adulthood: DSM-5-TR anorexia nervosa, restricting type, in later life; medical stabilization under the APA 2023 guideline, the SAHM 2022 medical management paper (written for younger patients and applied with care), the AED medical care standards and the ASPEN refeeding consensus (orthostatic vital signs, ECG for bradycardia and QTc, electrolytes with phosphate and magnesium, glucose, thiamine before nutrition, refeeding risk, and admission thresholds); bone density by DXA; a multidisciplinary team with an eating disorders psychiatrist, a dietitian and CBT-E; recurrent depression with persistent grief, with a structured safety assessment and a safety plan; a gastroenteritis that threatens potassium and the QTc on sertraline; preventive care at 56; the privacy of a public figure; and continuity of care for a patient who travels for weeks at a time.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| December 24, 1837 | Born in Munich. | CLM-0001 |
| April 24, 1854 | Married Emperor Franz Joseph I in Vienna. | CLM-0002 |
| 1859 to 1861 | A mysterious illness with cough, poor nutrition and exhaustion; winter on Madeira and months on Corfu. | CLM-0003 |
| from her twenties onward | Restrictive diets, frequent weighing, tight lacing and hours of daily exercise. | CLM-0004, CLM-0005, CLM-0006, CLM-0007, CLM-0011 |
| the early 1880s | Gave up riding because of health problems. | CLM-0007 |
| January 30, 1889 | Death of her son at Mayerling; mourning and deepening depression afterwards. | CLM-0012, CLM-0013 |
| the 1890s | Restless travel and the Achilleion on Corfu; swelling, pains and sciatica in her last years. | CLM-0014, CLM-0008, CLM-0009, CLM-0010 |
| 1894 | Lowest recorded weight, 43.5 kg. | CLM-0005 |
| September 10, 1898 | Stabbed in Geneva by an anarchist; died the same day. | CLM-0015 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Elisabeth Amalie Eugenie, Duchess in Bavaria, called Sisi, was born on December 24, 1837, in Munich, the daughter of Duke Max in Bavaria and Duchess Ludovika. | confirmed | Elisabeth (person page) supports Kaiserin Elisabeth supports |
| D | She married her cousin, Emperor Franz Joseph I, on April 24, 1854, in the Augustinerkirche in Vienna, and became Empress of Austria and, later, Queen of Hungary. She had four children. Context; no health fact about her husband or children is used in the modern episode. |
confirmed | Kaiserin Elisabeth supports Elisabeth (person page) supports |
| D | From about 1859 she was reported to suffer from a mysterious illness, with cough, poor nutrition, anemia and exhaustion; she spent the winter of 1860 to 1861 on Madeira and, after a relapse, four months on Corfu, and recovered quickly whenever she travelled. Early documented ill health; no diagnosis is adopted. |
probable | Mutschlechner M. Elisabeth's transformation supports Skårderud F. Speilets dronning. Skjønnhet, gymnastikk og melankoli. Keiserinne og dronning Elisabeth av Østerrike-Ungarn (1837-98). Tidsskrift for Norsk psykologforening 2008;45 (published June 30, 2008) supports |
| D | At 1.72 m she was unusually tall for a woman of her time, with an extremely slender figure. Gives her height; the modern height is set to it. |
confirmed | Mutschlechner M. Elisabeth's eccentric lifestyle supports Túry F, Babusa B, Varga M. History of eating disorders in Hungary. Psychiatria Danubina 2010;42(1):73-84 supports |
| D | Through her life she followed many diets; for periods each meal was a single food, such as egg, a milk product, orange or broth, and her 'magic weight' was fifty kilos. In her last years she weighed herself up to three times a day, and in 1894 she weighed as little as 43.5 kg, a body mass index of about 14.7 at her height. Documented restrictive eating and frequent weighing; the weights come from a biographical essay that relies on published biographies. Anchors the modern presenting problem. |
probable | Skårderud F. Speilets dronning. Skjønnhet, gymnastikk og melankoli. Keiserinne og dronning Elisabeth av Østerrike-Ungarn (1837-98). Tidsskrift for Norsk psykologforening 2008;45 (published June 30, 2008) supports Túry F, Babusa B, Varga M. History of eating disorders in Hungary. Psychiatria Danubina 2010;42(1):73-84 supports |
| D | Her waist measured only about 50 cm at its smallest, in tightly laced corsets and dresses sewn around it. Documented tight lacing. |
probable | Skårderud F. Speilets dronning. Skjønnhet, gymnastikk og melankoli. Keiserinne og dronning Elisabeth av Østerrike-Ungarn (1837-98). Tidsskrift for Norsk psykologforening 2008;45 (published June 30, 2008) supports Túry F, Babusa B, Varga M. History of eating disorders in Hungary. Psychiatria Danubina 2010;42(1):73-84 supports |
| D | She hiked for hours every day and had exercise rooms installed in her apartments; in the Vienna Hofburg the wall bars, high bar and rings are preserved, and she had a large gymnasium with heavy apparatus. She was one of the best horsewomen in Europe, but gave up riding at the beginning of the 1880s because of health problems. Documented excessive exercise; anchors the modern compulsive exercise. |
confirmed | Mutschlechner M. Elisabeth's eccentric lifestyle supports Dressing and Exercise Room (Imperial Apartments) supports |
| D | A psychiatrist's biographical essay writes that in her last years she was increasingly troubled by her undernutrition, with fluid accumulation in the body and severe bodily pains, and that she was diagnosed with chlorosis. Documented swelling and pain in her last years; chlorosis is the period diagnosis and is not adopted. |
probable | Skårderud F. Speilets dronning. Skjønnhet, gymnastikk og melankoli. Keiserinne og dronning Elisabeth av Østerrike-Ungarn (1837-98). Tidsskrift for Norsk psykologforening 2008;45 (published June 30, 2008) supports |
| R | Eating-disorder researchers write that she sometimes suffered from edema as a consequence of severe starvation. Retrospective interpretation of the swelling as hunger edema. |
probable | Túry F, Babusa B, Varga M. History of eating disorders in Hungary. Psychiatria Danubina 2010;42(1):73-84 supports |
| D | A Swiss newspaper reported in 2024 that letters kept by her spa physician at Bad Kissingen, found in the city archive, describe complaints including rheumatic attacks, sciatica, joint pain and hunger edema at the ankles. Newspaper report of archival letters; the dates of most letters are not given. Supports the brief's sciatica and ankle swelling. |
possible | So krank war Kaiserin Sisi wirklich: Weitere Krankenakte aufgetaucht supports |
| R | Psychiatrists and eating-disorder researchers have argued that she met the criteria for anorexia nervosa: one essay states that 'without doubt' she qualified, a German study describes fasting rituals, gymnastics, hours of riding, forced marches and a considerable fear of weight gain, and Hungarian researchers describe many features of anorexia nervosa and suggest it was closely related to depression. Retrospective diagnosis; she was never so diagnosed. Anchors the modern eating disorder, which is synthetic. |
probable | Skårderud F. Speilets dronning. Skjønnhet, gymnastikk og melankoli. Keiserinne og dronning Elisabeth av Østerrike-Ungarn (1837-98). Tidsskrift for Norsk psykologforening 2008;45 (published June 30, 2008) supports Vandereycken W, Abatzi T. Das anorektische Leben der Kaiserin Elisabeth von Österreich (1837-1898). Der Schlankheitskult im Hause Habsburg. Nervenarzt 1996;67(7):608-613. PMID 8927201 supports Túry F, Babusa B, Varga M. History of eating disorders in Hungary. Psychiatria Danubina 2010;42(1):73-84 supports |
| D | On January 30, 1889, her son, Crown Prince Rudolf, born in 1858, was found dead with a young woman at the Mayerling hunting lodge; historians regard as certain only that he killed her and then himself. Recorded once, plainly, without method detail. The modern episode refers only to the death of her son as a bereavement. |
confirmed | Rudolf (Kronprinz von Österreich-Ungarn) supports Skårderud F. Speilets dronning. Skjønnhet, gymnastikk og melankoli. Keiserinne og dronning Elisabeth av Østerrike-Ungarn (1837-98). Tidsskrift for Norsk psykologforening 2008;45 (published June 30, 2008) supports |
| D | It is said that her son's death prompted her to wear only mourning from then on. She suffered from ever-deepening depressions, which in her last years are thought to have developed into a kind of death-wish. Documented grief and depression; anchors the modern depression and safety assessment. Not a modern diagnosis. |
probable | Gruber S. Death of a European traveller supports Túry F, Babusa B, Varga M. History of eating disorders in Hungary. Psychiatria Danubina 2010;42(1):73-84 supports |
| D | After her son's death she sought to master her inner unrest with extended travels and a retreat to Corfu, where she had the Achilleion, a palatial villa, built; she lost interest in it once it was finished and left the island six years after its completion. She often travelled incognito. Places her in restless travel during the synthetic episode; her whereabouts in 1894 were not verified. |
confirmed | Kaiserin Elisabeth supports Schmöckel S. The Achilleion on Corfu: Elisabeth's flight into antiquity supports Gruber S. Death of a European traveller supports |
| D | On September 10, 1898, in Geneva, she was stabbed by an Italian anarchist and died; she was buried in the Imperial Crypt (Kapuzinergruft) in Vienna on September 17, 1898. After the episode. |
confirmed | Kaiserin Elisabeth supports Elisabeth (person page) supports Gruber S. Death of a European traveller supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Weight loss to a body mass index of 16.0 (47.4 kg at 172 cm), about 6 kg over six months, with fatigue, swelling of both ankles, dizziness on standing, slow pulse and cold intolerance; cause not established at intake; a restrictive eating disorder suspected, with thyroid disease, celiac disease, diabetes, malignancy and adrenal insufficiency to be excluded; eating disorders psychiatry consultation requested | resolved | confirmed | active | CLM-0005, CLM-0006, CLM-0007, CLM-0008, CLM-0009, CLM-0010 |
| S | Anorexia nervosa, restricting type, moderate (DSM-5-TR), with compulsive exercise and frequent self-weighing, beginning in early adulthood; complicated at diagnosis by sinus bradycardia, orthostatic dizziness, ankle edema, mild anemia and leukopenia, low glucose, raised ALT and low phosphate after refeeding began | active | confirmed | both_with_link | CLM-0005, CLM-0006, CLM-0007, CLM-0011 |
| S | Major depressive disorder, recurrent, moderate, with persistent grief for her son, who died five years ago; passive thoughts of death without intent or plan at intake | active | confirmed | active | CLM-0012, CLM-0013 |
| S | Acute viral gastroenteritis, caught from a member of her travelling party, with mild dehydration, orthostatic hypotension and mild hypokalemia; no purging behavior; managed with oral rehydration and potassium; resolved | resolved | confirmed | active | |
| S | Low bone mass (osteopenia) of the lumbar spine and hip after decades of low weight: lumbar spine T-score -2.1, femoral neck T-score -1.8; FRAX 10-year probabilities 6.8% for a major osteoporotic fracture and 1.2% for hip fracture; no fractures | active | confirmed | active | CLM-0005 |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 2026-02-03 | Hemoglobin [Mass/volume] in Blood | 11.2 g/dL (low) Reference 12-15.5 g/dL |
http://loinc.org · 718-7 |
| S | 2026-02-03 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 93 fL Reference 80-100 fL |
http://loinc.org · 787-2 |
| S | 2026-02-03 | Leukocytes [#/volume] in Blood by Automated count | 3.4 10*3/uL (low) Reference 4-11 10*3/uL |
http://loinc.org · 6690-2 |
| S | 2026-02-03 | Platelets [#/volume] in Blood by Automated count | 168 10*3/uL Reference 150-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 2026-02-03 | Sodium [Moles/volume] in Serum or Plasma | 136 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-02-03 | Potassium [Moles/volume] in Serum or Plasma | 3.6 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-02-03 | Urea nitrogen [Mass/volume] in Serum or Plasma | 21 mg/dL (high) Reference 7-20 mg/dL |
http://loinc.org · 3094-0 |
| S | 2026-02-03 | Creatinine [Mass/volume] in Serum or Plasma | 0.56 mg/dL (low) Reference 0.59-1.04 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-02-03 | Glucose [Mass/volume] in Serum or Plasma | 68 mg/dL (low) Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-02-03 | Magnesium [Mass/volume] in Serum or Plasma | 1.8 mg/dL Reference 1.7-2.2 mg/dL |
http://loinc.org · 19123-9 |
| S | 2026-02-03 | Phosphate [Mass/volume] in Serum or Plasma | 3 mg/dL Reference 2.5-4.5 mg/dL |
http://loinc.org · 2777-1 |
| S | 2026-02-03 | Albumin [Mass/volume] in Serum or Plasma | 4.1 g/dL Reference 3.5-5 g/dL |
http://loinc.org · 1751-7 |
| S | 2026-02-03 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 52 U/L (high) Reference 7-35 U/L |
http://loinc.org · 1742-6 |
| S | 2026-02-03 | Thyrotropin [Units/volume] in Serum or Plasma | 2.2 mIU/L Reference 0.45-4.5 mIU/L |
http://loinc.org · 3016-3 |
| S | 2026-02-03 | C reactive protein [Mass/volume] in Serum or Plasma | 1 mg/L Reference <=5 mg/L |
http://loinc.org · 1988-5 |
| S | 2026-02-03 | Tissue transglutaminase IgA Ab [Units/volume] in Serum | 0.8 U/mL Reference Below 4.0 is negative |
http://loinc.org · 31017-7 |
| S | 2026-02-03 | Ferritin [Mass/volume] in Serum or Plasma | 64 ng/mL Reference 15-150 ng/mL |
http://loinc.org · 2276-4 |
| S | 2026-02-03 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 22 ng/mL (low) Reference 30-100 ng/mL |
http://loinc.org · 62292-8 |
| S | 2026-02-03 | Q-T interval corrected | 438 ms Reference Above 460 ms is prolonged in women |
http://loinc.org · 8636-3 |
| S | 2026-02-03 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 107 mL/min/1.73 m² Reference 60 or more |
http://loinc.org · 98979-8 |
| S | 2026-02-03 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 16 | http://loinc.org · 44261-6 |
| S | 2026-03-24 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 13 | http://loinc.org · 44261-6 |
| S | 2026-05-26 | Sodium [Moles/volume] in Serum or Plasma | 134 mmol/L (low) Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-05-26 | Potassium [Moles/volume] in Serum or Plasma | 3.3 mmol/L (low) Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-05-26 | Urea nitrogen [Mass/volume] in Serum or Plasma | 24 mg/dL (high) Reference 7-20 mg/dL |
http://loinc.org · 3094-0 |
| S | 2026-05-26 | Creatinine [Mass/volume] in Serum or Plasma | 0.78 mg/dL Reference 0.59-1.04 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-05-26 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 89 mL/min/1.73 m² Reference 60 or more |
http://loinc.org · 98979-8 |
| S | 2026-05-26 | Glucose [Mass/volume] in Serum or Plasma | 72 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-05-26 | Magnesium [Mass/volume] in Serum or Plasma | 1.7 mg/dL Reference 1.7-2.2 mg/dL |
http://loinc.org · 19123-9 |
| S | 2026-05-26 | Phosphate [Mass/volume] in Serum or Plasma | 3 mg/dL Reference 2.5-4.5 mg/dL |
http://loinc.org · 2777-1 |
| S | 2026-05-26 | Q-T interval corrected | 452 ms Reference Above 460 ms is prolonged in women |
http://loinc.org · 8636-3 |
| S | 2026-02-10 | Sodium [Moles/volume] in Serum or Plasma | 137 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-02-10 | Potassium [Moles/volume] in Serum or Plasma | 3.7 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-02-10 | Glucose [Mass/volume] in Serum or Plasma | 74 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-02-10 | Magnesium [Mass/volume] in Serum or Plasma | 1.8 mg/dL Reference 1.7-2.2 mg/dL |
http://loinc.org · 19123-9 |
| S | 2026-02-10 | Phosphate [Mass/volume] in Serum or Plasma | 2.3 mg/dL (low) Reference 2.5-4.5 mg/dL |
http://loinc.org · 2777-1 |
| S | 2026-03-03 | Hemoglobin [Mass/volume] in Blood | 11.9 g/dL (low) Reference 12-15.5 g/dL |
http://loinc.org · 718-7 |
| S | 2026-03-03 | Leukocytes [#/volume] in Blood by Automated count | 3.9 10*3/uL (low) Reference 4-11 10*3/uL |
http://loinc.org · 6690-2 |
| S | 2026-03-03 | Sodium [Moles/volume] in Serum or Plasma | 138 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-03-03 | Potassium [Moles/volume] in Serum or Plasma | 3.9 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-03-03 | Glucose [Mass/volume] in Serum or Plasma | 80 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-03-03 | Magnesium [Mass/volume] in Serum or Plasma | 1.9 mg/dL Reference 1.7-2.2 mg/dL |
http://loinc.org · 19123-9 |
| S | 2026-03-03 | Phosphate [Mass/volume] in Serum or Plasma | 3.2 mg/dL Reference 2.5-4.5 mg/dL |
http://loinc.org · 2777-1 |
| S | 2026-03-03 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 38 U/L (high) Reference 7-35 U/L |
http://loinc.org · 1742-6 |
| S | 2026-03-03 | Q-T interval corrected | 436 ms Reference Above 460 ms is prolonged in women |
http://loinc.org · 8636-3 |
| S | 2026-03-03 | DXA Lumbar spine [T-score] Bone density | -2.1 (low) Reference -1.0 or higher is normal; -2.5 or lower is osteoporosis |
http://loinc.org · 38267-1 |
| S | 2026-03-03 | DXA Femur [T-score] Bone density | -1.8 (low) Reference -1.0 or higher is normal; -2.5 or lower is osteoporosis |
http://loinc.org · 38263-0 |
| S | 2026-03-03 | Major osteoporotic fracture 10-year probability [Likelihood] Fracture Risk Assessment | 6.8% | http://loinc.org · 90265-0 |
| S | 2026-03-03 | Hip fracture 10-year probability [Likelihood] Fracture Risk Assessment | 1.2% | http://loinc.org · 90266-8 |
| S | 2026-03-03 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 14 | http://loinc.org · 44261-6 |
| S | 2026-04-28 | Hemoglobin [Mass/volume] in Blood | 12.4 g/dL Reference 12-15.5 g/dL |
http://loinc.org · 718-7 |
| S | 2026-04-28 | Leukocytes [#/volume] in Blood by Automated count | 4.4 10*3/uL Reference 4-11 10*3/uL |
http://loinc.org · 6690-2 |
| S | 2026-04-28 | Sodium [Moles/volume] in Serum or Plasma | 137 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-04-28 | Potassium [Moles/volume] in Serum or Plasma | 4 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-04-28 | Magnesium [Mass/volume] in Serum or Plasma | 2 mg/dL Reference 1.7-2.2 mg/dL |
http://loinc.org · 19123-9 |
| S | 2026-04-28 | Phosphate [Mass/volume] in Serum or Plasma | 3.4 mg/dL Reference 2.5-4.5 mg/dL |
http://loinc.org · 2777-1 |
| S | 2026-04-28 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 30 U/L Reference 7-35 U/L |
http://loinc.org · 1742-6 |
| S | 2026-04-28 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 10 | http://loinc.org · 44261-6 |
| S | 2026-06-30 | Sodium [Moles/volume] in Serum or Plasma | 138 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-06-30 | Potassium [Moles/volume] in Serum or Plasma | 4.1 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-06-30 | Magnesium [Mass/volume] in Serum or Plasma | 2 mg/dL Reference 1.7-2.2 mg/dL |
http://loinc.org · 19123-9 |
| S | 2026-06-30 | Phosphate [Mass/volume] in Serum or Plasma | 3.6 mg/dL Reference 2.5-4.5 mg/dL |
http://loinc.org · 2777-1 |
| S | 2026-06-30 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 34 ng/mL Reference 30-100 ng/mL |
http://loinc.org · 62292-8 |
| S | 2026-06-30 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | http://loinc.org · 44261-6 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 2026-02-03 | Body height | 172 cm | 8302-2 | S |
| 2026-02-03 | Body weight | 47.4 kg | 29463-7 | S |
| 2026-02-03 | Body mass index (BMI) [Ratio] | 16 kg/m2 | 39156-5 | S |
| 2026-02-03 | Systolic blood pressure | 96 mm[Hg] | 8480-6 | S |
| 2026-02-03 | Diastolic blood pressure | 62 mm[Hg] | 8462-4 | S |
| 2026-02-03 | Heart rate | 52 /min | 8867-4 | S |
| 2026-02-03 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-02-03 | Body temperature | 36 Cel | 8310-5 | S |
| 2026-02-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-02-10 | Body height | 172 cm | 8302-2 | S |
| 2026-02-10 | Body weight | 47.9 kg | 29463-7 | S |
| 2026-02-10 | Body mass index (BMI) [Ratio] | 16.2 kg/m2 | 39156-5 | S |
| 2026-02-10 | Systolic blood pressure | 98 mm[Hg] | 8480-6 | S |
| 2026-02-10 | Diastolic blood pressure | 62 mm[Hg] | 8462-4 | S |
| 2026-02-10 | Heart rate | 54 /min | 8867-4 | S |
| 2026-02-10 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-02-10 | Body temperature | 36.1 Cel | 8310-5 | S |
| 2026-02-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-03-03 | Body height | 172 cm | 8302-2 | S |
| 2026-03-03 | Body weight | 49.6 kg | 29463-7 | S |
| 2026-03-03 | Body mass index (BMI) [Ratio] | 16.8 kg/m2 | 39156-5 | S |
| 2026-03-03 | Systolic blood pressure | 100 mm[Hg] | 8480-6 | S |
| 2026-03-03 | Diastolic blood pressure | 64 mm[Hg] | 8462-4 | S |
| 2026-03-03 | Heart rate | 56 /min | 8867-4 | S |
| 2026-03-03 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-03-03 | Body temperature | 36.2 Cel | 8310-5 | S |
| 2026-03-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-04-28 | Body height | 172 cm | 8302-2 | S |
| 2026-04-28 | Body weight | 52 kg | 29463-7 | S |
| 2026-04-28 | Body mass index (BMI) [Ratio] | 17.6 kg/m2 | 39156-5 | S |
| 2026-04-28 | Systolic blood pressure | 104 mm[Hg] | 8480-6 | S |
| 2026-04-28 | Diastolic blood pressure | 66 mm[Hg] | 8462-4 | S |
| 2026-04-28 | Heart rate | 60 /min | 8867-4 | S |
| 2026-04-28 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-04-28 | Body temperature | 36.4 Cel | 8310-5 | S |
| 2026-04-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-06-30 | Body height | 172 cm | 8302-2 | S |
| 2026-06-30 | Body weight | 54 kg | 29463-7 | S |
| 2026-06-30 | Body mass index (BMI) [Ratio] | 18.3 kg/m2 | 39156-5 | S |
| 2026-06-30 | Systolic blood pressure | 106 mm[Hg] | 8480-6 | S |
| 2026-06-30 | Diastolic blood pressure | 68 mm[Hg] | 8462-4 | S |
| 2026-06-30 | Heart rate | 62 /min | 8867-4 | S |
| 2026-06-30 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-06-30 | Body temperature | 36.5 Cel | 8310-5 | S |
| 2026-06-30 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-03-24 | Body height | 172 cm | 8302-2 | S |
| 2026-03-24 | Body weight | 50.4 kg | 29463-7 | S |
| 2026-03-24 | Body mass index (BMI) [Ratio] | 17 kg/m2 | 39156-5 | S |
| 2026-03-24 | Systolic blood pressure | 100 mm[Hg] | 8480-6 | S |
| 2026-03-24 | Diastolic blood pressure | 64 mm[Hg] | 8462-4 | S |
| 2026-03-24 | Heart rate | 58 /min | 8867-4 | S |
| 2026-03-24 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-03-24 | Body temperature | 36.3 Cel | 8310-5 | S |
| 2026-03-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-05-26 | Body height | 172 cm | 8302-2 | S |
| 2026-05-26 | Body weight | 51 kg | 29463-7 | S |
| 2026-05-26 | Body mass index (BMI) [Ratio] | 17.2 kg/m2 | 39156-5 | S |
| 2026-05-26 | Systolic blood pressure | 96 mm[Hg] | 8480-6 | S |
| 2026-05-26 | Diastolic blood pressure | 60 mm[Hg] | 8462-4 | S |
| 2026-05-26 | Heart rate | 74 /min | 8867-4 | S |
| 2026-05-26 | Respiratory rate | 16 /min | 9279-1 | S |
| 2026-05-26 | Body temperature | 37.6 Cel | 8310-5 | S |
| 2026-05-26 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S A public figure who avoids public appearances; travels for weeks at a time, often incognito, and spends part of the year at a villa on a Greek island
- S Married, living apart from her husband for much of the year; adult daughters; staff travel with her
- S Exercise: walks four to six hours a day at a fast pace in all weather, and does gymnastics on wall bars and rings each morning; feels anxious if she cannot
- S Tobacco: never. Alcohol: none. No other drugs. No laxatives, diuretics, diet pills or self-induced vomiting
- S Weighs herself up to three times a day on her own scales and keeps her weight below a fixed number
Functional status
- S Independent; tires on stairs, feels faint on standing quickly, and has cut back on reading and correspondence because she cannot concentrate
Mental status
- S Very thin, tall woman dressed in black; guarded, courteous and articulate; mood low, affect constricted; preoccupied with her weight and shape; passive thoughts of being better off dead, without intent or plan; no psychotic features; insight partial
Structured safety assessment
This assessment is synthetic and does not convert historical behavior into a present-day fact.
Allergies and medications
Allergies
- S No known allergy
Medications
- S Thiamine 100 mg tablet, one by mouth daily for 14 days, starting before the meal plan
- S Cholecalciferol 50 microgram (2,000 IU) capsule, one by mouth daily
- S Potassium chloride 20 mEq extended-release tablet, one by mouth daily with food for three days
- S Phosphorus 250 mg tablet (potassium and sodium phosphates), one by mouth twice daily with meals for three weeks
- S Calcium carbonate 1,250 mg (500 mg elemental calcium) tablet, one by mouth daily with a meal
- S Sertraline 25 mg tablet, one by mouth each morning for two weeks
- S Sertraline 50 mg tablet, one by mouth each morning
Procedures and immunizations
Procedures
- S Resting twelve-lead electrocardiogram
- S Advance care planning conversation, about 20 minutes
- S Resting twelve-lead electrocardiogram
- S Dual-energy X-ray absorptiometry (DXA) of the lumbar spine and hip
- S Resting twelve-lead electrocardiogram
Immunizations
- S 2026-03-24: Recombinant zoster vaccine, dose 1 of 2
- S 2026-03-24: Pneumococcal conjugate vaccine (PCV20)
- S 2026-03-24: Tdap vaccine
- S 2026-06-30: Recombinant zoster vaccine, dose 2 of 2
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D her early twenties: A prolonged illness in early adulthood with cough, poor nutrition, anemia and exhaustion, which improved with time away by the sea (CLM-0003)
- D since her late teens: Restrictive dieting since early adulthood, with single-food meals, a fixed upper weight of 50 kg, tight lacing to a waist of about 50 cm, and hours of walking and gymnastics every day (CLM-0005, CLM-0006, CLM-0007)
- D her forties: Gave up horse riding in her forties because of health problems not specified in the cited source (CLM-0007)
- D recent years: Swelling, bodily pains and sciatica in recent years, called hunger edema in letters from a spa (CLM-0008, CLM-0010)
- D January 1889: Mourning and deepening depression since the death of her son five years ago (CLM-0012, CLM-0013)
Family history
No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| Medically stable for outpatient care: resting pulse 50 or more, no orthostatic dizziness, and normal potassium, phosphate, magnesium and glucose | 2026-03-03 | completed | Pulse 56, orthostatic changes resolved, electrolytes and glucose normal at four weeks |
| Weight gain of about 0.5 to 1 kg a week toward a body mass index of at least 18.5 | 2026-08-31 | active | From 47.4 kg (BMI 16.0) to 54.0 kg (BMI 18.3) at twenty-one weeks; still gaining |
| Depression response (PHQ-9 down by at least 50 percent) by six months | 2026-06-30 | completed | PHQ-9 7 at twenty-one weeks, down 56 percent from 16 |
| Exercise reduced to walks of an hour or less a day while weight is restored, with no gymnastics until the team agrees | 2026-04-28 | completed | Walks of about an hour a day; gymnastics stopped |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Eating disorders psychiatry consultation in one week to confirm the diagnosis, decide the level of care, and lead a multidisciplinary plan | completed | GL-APA-ED-2023, GL-AED-MCS-2021 |
| Medical assessment and stabilization: orthostatic vital signs and temperature, ECG, blood count, electrolytes with phosphate and magnesium, glucose, kidney and liver tests, albumin, TSH, CRP, ferritin and vitamin D; admission criteria explained; electrolytes, phosphate and magnesium to be rechecked three to four days after the meal plan starts, then weekly for the first weeks | completed | GL-APA-ED-2023, GL-SAHM-ED-2022, GL-AED-MCS-2021 |
| Refeeding risk: thiamine 100 mg daily before and during the first two weeks, and a starting meal plan of about 1,600 kcal a day in three meals and two snacks, increased by about 200 to 300 kcal every few days | completed | GL-ASPEN-REFEED-2020, GL-SAHM-ED-2022 |
| Collaborative safety plan with warning signs, coping steps, people to contact including her travelling companion, the clinic number, the 988 Suicide & Crisis Lifeline and local emergency numbers abroad; medicines dispensed in small supplies and kept by her companion | completed | GL-SUICIDE-2024 |
| Privacy: the chart is flagged as restricted, access is audited, she is booked under a scheduling alias at the first or last appointment of the day, and weights are discussed only in the consulting room | completed | GL-APA-ED-2023 |
| Multidisciplinary outpatient treatment: weekly CBT-E with an eating disorders therapist, a dietitian twice a month, medical review by the primary clinician, and psychiatry review; open weighing at sessions instead of weighing at home; by video when she travels | completed | GL-APA-ED-2023, GL-NICE-NG69 |
| Compulsive exercise: no gymnastics and walks of no more than an hour a day while weight is restored and the pulse and orthostatic changes are abnormal, with a graded return agreed by the team | completed | GL-APA-ED-2023, GL-SAHM-ED-2022 |
| Bone health: DXA of the spine and hip, calcium 1,200 mg a day from food and supplement, vitamin D, weight restoration as the main treatment, and repeat DXA in two years | completed | GL-CMID-2026, GL-USPSTF-OST-2025, GL-APA-ED-2023 |
| Depression with persistent grief: grief-focused work within therapy; sertraline 25 mg daily, increased to 50 mg after two weeks, once nutrition was under way and the QTc was normal; PHQ-9 at every visit and suicide-risk review at every visit | completed | GL-CMID-2026, GL-MDD-2022, GL-SUICIDE-2024 |
Planned encounters
- 2026-02-03 — New patient visit for weight loss, fatigue, ankle swelling and dizziness: history, examination with orthostatic vital signs, ECG, blood tests, depression and safety screening, a start to nutrition with thiamine, and an eating disorders psychiatry referral (ENC-001)
- 2026-02-10 — One-week medical stabilization check and eating disorders psychiatry consultation (ENC-002)
- 2026-03-03 — Four-week review: weight, vital signs, electrolytes, bone density, and depression (ENC-003)
- 2026-03-24 — Periodic adult preventive visit (ENC-006)
- 2026-04-28 — Twelve-week review: weight restoration, exercise, mood and sertraline (ENC-004)
- 2026-05-26 — Same-day sick visit for vomiting and diarrhea (ENC-007, unscheduled)
- 2026-06-30 — Twenty-one-week review: weight, mood, the gastroenteritis, and care while travelling (ENC-005)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Focused Visit (Follow-up)
- Progress note 04 — Preventive Visit
- Progress note 05 — Focused Visit (Follow-up)
- Progress note 06 — Sick Visit
- Progress note 07 — Focused Visit (Care-plan review)
- Psychiatry (eating disorders) referral
- Psychiatry (eating disorders) consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Focused Visit (Follow-up) (XML)
- Progress note 04 — Preventive Visit (XML)
- Progress note 05 — Focused Visit (Follow-up) (XML)
- Progress note 06 — Sick Visit (XML)
- Progress note 07 — Focused Visit (Care-plan review) (XML)
- Psychiatry (eating disorders) referral (XML)
- Psychiatry (eating disorders) consultation (XML)
Sources
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check the DSM-5-TR diagnosis of anorexia nervosa, restricting type, moderate, in a woman of 56; outpatient care at a BMI of 16.0 with the admission thresholds stated; thiamine and the starting calories; the missed early electrolyte check and the phosphate supplement; DXA and calcium and vitamin D without a bone drug; sertraline started after the QTc was normal; the gastroenteritis plan avoiding ondansetron; and the safety plan. |
| provenance review | not_started | A Norwegian psychiatrist's biographical essay (read in full), a Hungarian peer-reviewed history (read in full), a German study (abstract), the City of Vienna history wiki, the Schönbrunn Group's history site and the Sisi Museum, and a newspaper report of archival letters logged. The retrospective anorexia nervosa diagnosis and the interpretation of her swelling as hunger edema are graded R. |
| safe messaging review | not_started | Her son's death at Mayerling is recorded once, in one claim marked sensitive, without method detail; the modern episode refers only to the death of her son. Her documented depression and death-wish are marked sensitive. The modern safety assessment records passive thoughts of death without intent or plan, with a safety plan and the 988 Suicide & Crisis Lifeline. Weights and calorie numbers are clinical data and are not presented as targets. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.